Cathie Wood's $362 Million CRISPR Bet: Hidden Catalyst
Cathie Wood’s big bet on CRISPR Therapeutics signals more than faith in gene editing. This article digs into the unde...
Travel credit cards come with various features that can enhance your travel experience. Learn essential insights to maximize your benefits.
25,344 articlesCathie Wood’s big bet on CRISPR Therapeutics signals more than faith in gene editing. This article digs into the unde...
As Semtech gears up for its 2026 results, investors want concrete takeaways on growth drivers, margins, and capital d...
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
As AI drives demand for faster memory, Micron sits at the center of a cyclical industry that can fuel outsized moves....
When a company director sells millions after a sharp rally, it stirs worry. But insider activity is nuanced. This gui...
When insiders sell, investors watch closely. This article unpacks a recent move at Laureate Education and translates ...
The Trade Desk has faced a tough stretch, but patient investors are asking if the trade desk stock finally offers a p...
Wolverine Worldwide's Q1 2026 earnings call offers a clear view of the company's momentum, margins, and strategic bet...
The prospect of SpaceX going public has investors buzzing. History shows mega IPOs behave in patterns that can surpri...
Lululemon faces a pivotal moment after its latest earnings. This analysis breaks down what's working, what's slowing,...
Nebius has sprinted ahead in 2026, climbing 170% as AI infrastructure accelerates. This article breaks down the drive...
A high-profile nod from a tech legend can spark instant moves in AI chip stocks. This guide explains how to separate ...